Boosting angiogenesis and functional vascularization in injectable dextran-hyaluronic acid hydrogels by endothelial-like mesenchymal stromal cells

Tissue Engineering - Part A

Volumn 20, Issue 3-4, 2014, Pages 819-829

  Portalska, Karolina Janeczek ^a   Teixeira, Liliana Moreira ^a,c   Leijten, Jeroen C H ^a,c   Jin, Rong ^b   Van Blitterswijk, Clemens ^a   De Boer, Jan ^a   Karperien, Marcel ^a  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b SHANGHAI UNIVERSITY   (China)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL ENGINEERING; DEXTRAN; FLOWCHARTING; HYALURONIC ACID; HYDROGELS; ORGANIC ACIDS; TISSUE;

ACUTE INFLAMMATORY RESPONSE; ANGIOGENIC GROWTH FACTORS; DELIVERY METHODS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; MESENCHYMAL STROMAL CELLS; NEO-VASCULARIZATION; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR NETWORK;

ENDOTHELIAL CELLS;

BIOMATERIAL; DEXTRAN; HYALURONIC ACID; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL TYPE; CONTROLLED STUDY; ENDOTHELIAL LIKE MESENCHYMAL STROMAL CELL; HUMAN; HUMAN CELL; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INJECTION; ISCHEMIA; MALE; MESENCHYMAL STROMA CELL; METABOLIC RATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE ENGINEERING; VASCULARIZATION;

ANIMALS; ANTIGENS, CD31; BIOLOGICAL MARKERS; CAPILLARIES; CELL SURVIVAL; CELLS, CULTURED; CHICKENS; DEXTRANS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYALURONIC ACID; HYDROGELS; INFLAMMATION; INJECTIONS; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC; TISSUE SCAFFOLDS;

EID: 84894113932     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2013.0280     Document Type: Article

References (37)

1. Radisic, M., Malda, J., Epping, E., Geng, W., Langer, R., et al. Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol Bioeng 93, 332, 2006.
2. Rouwkema, J., Rivron, N.C., and van Blitterswijk, C.A. Vascularization in tissue engineering. Trends Biotechnol 26, 434, 2008.
3. Lovett, M., Lee, K., Edwards, A., and Kaplan, D.L. Vascu-larization strategies for tissue engineering. Tissue Eng Part B Rev 15, 353, 2009.
4. Richardson, T.P., Peters, M.C., Ennett, A.B., and Mooney, D.J. Polymeric system for dual growth factor delivery. Nat Biotechnol 19, 1029, 2001.
5. Levenberg, S., Rouwkema, J., Macdonald, M., Garfein, E.S., Kohane, D.S., et al. Engineering vascularized skeletal muscle tissue. Nat Biotechnol 23, 879, 2005.
6. Rouwkema, J., Westerweel, P.E., de Boer, J., Verhaar, M.C., and van Blitterswijk, C.A. The use of endothelial progenitor cells for prevascularized bone tissue engineering. Tissue Eng Part A 15, 2015, 2009.
7. Krenning, G., van Luyn, M.J., and Harmsen, M.C. En-dothelial progenitor cell-based neovascularization: implications for therapy. Trends Mol Med 15, 180, 2009.
8. Hristov, M., Erl, W., and Weber, P.C. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 23, 1185, 2003.
9. Hristov, M., and Weber, C. The therapeutic potential of progenitor cells in ischemic heart disease-past, present and future. Basic Res Cardiol 101, 1, 2006.
10. Salomon, R.N., Hughes, C.C., Schoen, F.J., Payne, D.D., Pober, J.S., et al. Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. Am J Pathol 138, 791, 1991.
11. Nerem, R.M., and Seliktar, D. Vascular tissue engineering. Annu Rev Biomed Eng 3, 225, 2001.
12. Janeczek Portalska, K., Leferink, A., Groen, N., Fernandes, H., Moroni, L., et al. Endothelial differentiation of mesen-chymal stromal cells. PLoS One 7, e46842, 2012.
13. Prestwich, G.D. Simplifying the extracellular matrix for 3-D cell culture and tissue engineering: a pragmatic approach. J Cell Biochem 101, 1370, 2007.
14. Jin, R., Moreira Teixeira, L.S., Dijkstra, P.J., van Blitterswijk, C.A., Karperien, M., et al. Chondrogenesis in injectable en-zymatically crosslinked heparin/dextran hydrogels. J Control Release 152, 186, 2011.
15. Moreira Teixeira, L.S., Leijten, J.C., Wennink, J.W., Chatter-jea, A.G., Feijen, J., et al. The effect of platelet lysate supplementation of a dextran-based hydrogel on cartilage formation. Biomaterials 33, 3651, 2012.
16. Jin, R., Teixeira, L.S., Dijkstra, P.J., van Blitterswijk, C.A., Kar-perien, M., et al. Enzymatically-crosslinked injectable hydrogels based on biomimetic dextran-hyaluronic acid conjugates for cartilage tissue engineering. Biomaterials 31, 3103, 2010.
17. Hanjaya-Putra, D., Wong, K.T., Hirotsu, K., Khetan, S., Burdick, J.A., et al. Spatial control of cell-mediated degradation to regulate vasculogenesis and angiogenesis in hya-luronan hydrogels. Biomaterials 33, 6123, 2012.
18. Lennon, F.E., and Singleton, P.A. Hyaluronan regulation of vascular integrity. Am J Cardiovasc Dis 1, 200, 2011.
19. Jukes, J.M., Moroni, L., van Blitterswijk, C.A., and de Boer, J. Critical steps toward a tissue-engineered cartilage implant using embryonic stem cells. Tissue Eng A 14, 135, 2008.
20. Pink, D.B.S., Schulte, W., Parseghian, M.H., Zijlstra, A., and Lewis, J.D. Real-time visualization and quantitation of vascular permeability in vivo: implications for drug delivery. PLoS One 7, e33760, 2012.
21. Silva, E.A., and Mooney, D.J. Effects of VEGF temporal and spatial presentation on angiogenesis. Biomaterials 31, 1235, 2010.
22. Moses, M.A. The regulation of neovascularization by matrix metalloproteinases and their inhibitors. Stem Cells 15, 180, 1997.
23. Davis, G.E., Koh, W., and Stratman, A.N. Mechanisms controlling human endothelial lumen formation and tube assembly in three-dimensional extracellular matrices. Birth Defects Res C Embryo Today 81, 270, 2007.
24. Kniazeva, E., and Putnam, A.J. Endothelial cell traction and ECM density influence both capillary morphogenesis and maintenance in 3-D. Am J Physiol Cell Physiol 297, C179, 2009.
25. Hanjaya-Putra, D., Bose, V., Shen, Y.I., Yee, J., Khetan, S., et al. Controlled activation of morphogenesis to generate a functional human microvasculature in a synthetic matrix. Blood 118, 804, 2011.
26. Ferreira, L.S., Gerecht, S., Fuller, J., Shieh, H.F., Vunjak-Novakovic, G., et al. Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. Biomaterials 28, 2706, 2007.
27. Sun, G., Shen, Y.I., Kusuma, S., Fox-Talbot, K., Steenbergen, C.J., et al. Functional neovascularization of biodegradable dextran hydrogels with multiple angiogenic growth factors. Biomaterials 32, 95, 2011.
28. Hanjaya-Putra, D., Yee, J., Ceci, D., Truitt, R., Yee, D., et al. Vascular endothelial growth factor and substrate mechanics regulate in vitro tubulogenesis of endothelial progenitor cells. J Cell Mol Med 14, 2436, 2010.
29. Zhang, W.J., Liu, W., Cui, L., and Cao, Y. Tissue engineering of blood vessel. J Cell Mol Med 11, 945, 2007.
30. Oswald, J., Boxberger, S., Jorgensen, B., Feldmann, S., Eh-ninger, G., et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22, 377, 2004.
31. Liu, J.W., Dunoyer-Geindre, S., Serre-Beinier, V., Mai, G., Lambert, J.F., et al. Characterization of endothelial-like cells derived from human mesenchymal stem cells. J Thromb Haemost 5, 826, 2007.
32. Doorn, J., Moll, G., Le Blanc, K., van Blitterswijk, C., and de Boer, J. Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements. Tissue Eng Part B Rev 18, 101, 2012.
33. Cox, T.R., and Erler, J.T. Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis Model Mech 4, 165, 2011.
34. Gillies, R.J., Robey, I., and Gatenby, R.A. Causes and consequences of increased glucose metabolism of cancers. J Nucl Med 49 Suppl 2, 24S, 2008.
35. Ravi, S., and Chaikof, E.L. Biomaterials for vascular tissue engineering. Regen Med 5, 107, 2010.
36. Tian, L., and George, S.C. Biomaterials to prevascularize engineered tissues. J Cardiovasc Transl Res 4, 685, 2011.
37. Rouwkema, J., Rivron, N.C., Bettahalli, N.M.S., Stamatialis, D., Wessling, M., et al. Mesenchymal stem cells differentiate towards endothelial cells in a prevascularized bone tissue engineering setting. Tissue Eng Part A. 15, 2015, 2009.